Cargando…
The Use of Positron Emission Tomography in Soft Tissue Sarcoma Patients under Therapy with Trabectedin
BACKGROUND: We used 2-deoxy-2-[(18)F] fluoro-D-glucose (FDG) positron emission tomography (PET) to evaluate the FDG uptake in patients with advanced and/or metastatic soft tissue sarcoma (STS) undergoing therapy with Ecteinascidin-743 (ET-743, Trabectedin, Yondelis™). PATIENTS AND METHODS: The pilot...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Molecular Diversity Preservation International
2009
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2763103/ https://www.ncbi.nlm.nih.gov/pubmed/19841717 http://dx.doi.org/10.3390/md7030331 |